Shuttle Unique Capabilities!

Bobby Martin shared REAL Space Act of 2013's photo.

Just now · 

As our experts have stated, the many unique capabilities of shuttle plus the maintenance of our skills are lost, As clearly indicated by nasaproblems.com , Don Nelson , all this manned space flight down time coupled with China' s intent to have an operational reuseable shuttle, clearly places the USA in serious situation! YET, the media will not bring facts to the people! Spread the word!!

REAL Space Act of 2013

Never should have been retired!

###

Did you know that United Space Alliance (USA) submitted a proposal to fly the shuttles as a commercial service for NASA?

...See More

Sent from my iPad

Fwd: Fighting Breast Cancer Hormone-Therapy Resistance; New Ways to Drain Cancer's Fuel Tank

Sent from my iPad

Begin forwarded message:

From: Kent Castle <kent.d.castle@hotmail.com>
Date: November 25, 2014 at 5:19:32 PM CST
To: Bogan Carole <bcbogan@earthlink.net>, Reason Marilou <loganlou55@yahoo.com>, Patterson James <w8ljz@aol.com>, Astrology Valkyrie <astrogoddess@valkyrieastrology.com>, Bentz Jerry <bentz@sbcglobal.net>, Baird Darren <darren.t.baird@nasa.gov>, Martin Bobby <bobbygmartin1938@gmail.com>
Subject: FW: Fighting Breast Cancer Hormone-Therapy Resistance; New Ways to Drain Cancer's Fuel Tank

 

---

From: reply@mail.dddmag.com
To: KENT.D.CASTLE@HOTMAIL.COM
Subject: Fighting Breast Cancer Hormone-Therapy Resistance; New Ways to Drain Cancer's Fuel Tank
Date: Tue, 25 Nov 2014 10:12:59 -0600

Mali Confirms Eighth Ebola Case; Vascular Solutions Gets Clearance for Tumor Treating Gel-Block

View this email in your browser. NOV 25   IN THIS ISSUE   NEWS     Researchers Identify New Ways to Drain Cancer's 'Fuel Tank'     NEWS     Mali Confirms Eighth Ebola Case     NEWS     Vascular Solutions Gets Clearance for Tumor Treating Gel-Block     NEWS     $1B Alliance Between Menarini, Oxford BioTherapeutics for Enhanced AML Treatment     NEWS     Genetic Test Unlocks Cause of Brisbane Boy's Rare Disease   Pittcon 2015 Pittcon 2015, the world's largest annual conference & expo for laboratory science, March 8-12, 2015, New Orleans, LA. Pittcon offers a premiere exposition, diverse technical program, unique networking & exceptional short courses LEARN MORE     FEATURED STORY Exciting Gains in Fighting Breast Cancer Hormone-Therapy Resistance     Guided by breakthrough research on the Estrogen Receptor 1 (ESR1 ) gene, many researchers and pharmaceutical companies are in hot pursuit of the next big anti-resistance breast cancer drug. Read more...                  Share FULL STORY     10th Annual World Stem Cell Summit The 10th Annual World Stem Cell Summit is the largest interdisciplinary stem cell meeting with organizers from the Mayo Clinic, Kyoto Univ., the Univ. of Texas Health Science Center, BioBridge Global, and many more. You won't want to miss this year's event with NEW tracks focusing on Discovery, Translation and Clinical Trials, Innovation Showcase, Regenerative Services and Capital Markets. LEARN MORE     NEWS Researchers Identify New Ways to Drain Cancer's 'Fuel Tank' Scientists at the University of Manchester have discovered a potential weakness in cancer's ability to return or become resistant to treatment. Read more...                   FULL STORY     NEWS Mali Confirms Eighth Ebola Case Mali has confirmed a new case of Ebola, bringing to eight the number of people who have fallen ill with the deadly disease in the West African country. Read more...                 FULL STORY     NEWS Vascular Solutions Gets Clearance for Tumor Treating Gel-Block Vascular Solutions gets clearance from the FDA for tumor treating gel blocks. Read more...                              FULL STORY     NEWS $1B Alliance Between Menarini, Oxford BioTherapeutics for Enhanced AML Treatment This is the first of five development programs between the two companies to enter the clinic in a $1 billion strategic oncology alliance. Read more...                    FULL STORY     NEWS Genetic Test Unlocks Cause of Brisbane Boy's Rare Disease Queensland researchers have led an international effort to uncover the gene behind a young Brisbane boy's rare developmental condition. Read more...                    FULL STORY   SUBSCRIBE • UNSUBSCRIBE • ABOUT US • ADVERTISE This email was sent by: Drug Discovery & Development 100 Enterprise Drive - Suite 600 - Rockaway, NJ 07866-2129 We respect your right to privacy - click here to view our policy. ©2014 Drug Discovery & Development. All rights reserved.

Keep the shuttle flying: Fwd: On-off aging switch; Protein adhesives shine underwater; Glimpse of "forbidden" spectra

http://keeptheshuttleflyingc.blogspot.com/2014/09/fwd-on-off-aging-switch-protein.html


Sent from my iPad

Fwd: Google Alert - Space cancer research

Sent from my iPad

Begin forwarded message:

From: Google Alerts <googlealerts-noreply@google.com>
Date: September 9, 2014 12:00:19 PM CDT
To: bobbygmartin1938@gmail.com
Subject: Google Alert - Space cancer research

	Space cancer research Daily update ⋅ September 9, 2014
	NEWS
	Discover Magazine (blog) Cancer Research is Rocketing into Space and You are Invited to Take the Pilot's Seat Discover Magazine (blog) In Discover Magazine's November print issue the article 'Trial and Error' talks about the many reasons why progress in cancer research is slow. Flag as irrelevant
Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback

Fwd: Delivery Status Notification (Failure)

Sent from my iPad

Begin forwarded message:

From: Mail Delivery Subsystem <mailer-daemon@google.com>
Date: September 7, 2014 10:06:33 PM CDT
To: bobbygmartin1938@gmail.com
Subject: Delivery Status Notification (Failure)

Delivery to the following recipient failed permanently:

    bobbygmartin1938.casperc@blogger.com

----- Original message -----

X-Received: by 10.66.227.37 with SMTP id rx5mr15027308pac.25.1410145593206;
       Sun, 07 Sep 2014 20:06:33 -0700 (PDT)
Return-Path: <bobbygmartin1938@gmail.com>
Received: from mail-ob0-x231.google.com (mail-ob0-x231.google.com [2607:f8b0:4003:c01::231])
       by gmr-mx.google.com with ESMTPS id tr5si837776igb.1.2014.09.07.20.06.33
       for <bobbygmartin1938.casperc@blogger.com>
       (version=TLSv1 cipher=ECDHE-RSA-RC4-SHA bits=128/128);
       Sun, 07 Sep 2014 20:06:33 -0700 (PDT)
Received-SPF: pass (google.com: domain of bobbygmartin1938@gmail.com designates 2607:f8b0:4003:c01::231 as permitted sender) client-ip=2607:f8b0:4003:c01::231;
Authentication-Results: gmr-mx.google.com;
      spf=pass (google.com: domain of bobbygmartin1938@gmail.com designates 2607:f8b0:4003:c01::231 as permitted sender) smtp.mail=bobbygmartin1938@gmail.com;
      dkim=pass header.i=@gmail.com;
      dmarc=pass (p=NONE dis=NONE) header.from=gmail.com
Received: by mail-ob0-f177.google.com with SMTP id wo20so10158539obc.22
       for <bobbygmartin1938.casperc@blogger.com>; Sun, 07 Sep 2014 20:06:32 -0700 (PDT)
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed;
       d=gmail.com; s=20120113;
       h=subject:references:from:content-type:message-id:date:to
        :content-transfer-encoding:mime-version;
       bh=QE9B8idscxbjQPUFtP4LnJiRwCiLFgx0DKLCxvjTmGI=;
       b=RY041ICyAM8BZo+sd8ivYXQ4SkY07tIojYTFdQau/JcUqMUBiiq+rY59nHSfbANJSQ
        zB+BntdrqiJ0G/Ke7t8/sBGNYzPYGxRS4ClwbTW+ydttC+zg/7oMtFEjoLXBvc5zcSYc
        CD/vOLyVP69/AX8oGMYapiTOll3WfWX/8MDvFaRHDp/nsIvCDY5yoEn9qS0qWIPTdYzV
        VpgMx+qFgErtrV6BghgP8KTOSTj7dlBb1bCTZprVwA6w2dw9aasdaToePIytrks/TqPe
        UXfRTnJKGo1/zgALS/l6sQADZ+1imootfqIu5nQLTrbkMYKhJSuUYNFElD7Vc2zWwo63
        Wwhw==
X-Received: by 10.60.161.49 with SMTP id xp17mr30457375oeb.18.1410145592808;
       Sun, 07 Sep 2014 20:06:32 -0700 (PDT)
Return-Path: <bobbygmartin1938@gmail.com>
Received: from [192.168.1.33] (65-255-71-225.dyn.hsi.pldi.net. [65.255.71.225])
       by mx.google.com with ESMTPSA id vc4sm5721210obb.10.2014.09.07.20.06.31
       for <bobbygmartin1938.casperc@blogger.com>
       (version=TLSv1 cipher=ECDHE-RSA-RC4-SHA bits=128/128);
       Sun, 07 Sep 2014 20:06:32 -0700 (PDT)
Subject: Fwd: Google Alert - Cancer research
References: <001a11c30ca8406df5050285059b@google.com>
From: Bobby Martin <bobbygmartin1938@gmail.com>
Content-Type: multipart/alternative;
   boundary=Apple-Mail-1-194188460
X-Mailer: iPad Mail (8H7)
Message-Id: <EDC06CB6-E91B-4742-84CA-559D04029C37@gmail.com>
Date: Sun, 7 Sep 2014 22:06:38 -0500
To: bobbygmartin1938.casperc@blogger.com
Content-Transfer-Encoding: 7bit
Mime-Version: 1.0 (iPad Mail 8H7)



Sent from my iPad

Begin forwarded message:

From: Google Alerts <googlealerts-noreply@google.com>

Date: September 7, 2014 10:00:25 PM CDT

To: bobbygmartin1938@gmail.com

Subject: Google Alert - Cancer research

       

Cancer research

Daily update ⋅ September 8, 2014

NEWS    

'Stand Up 2 Cancer' makes big money for cancer research

Today.com

Video: Last night's Stand Up 2 Cancer telethon featured some of the biggest stars in Hollywood, raising money for cancer research. NBC's Miguel ...

                  Flag as irrelevant  

KOMO News

Crews raise sails to support breast cancer research

KOMO News

SEATTLE - As a sailor, Michele Bennett of Bellingham has fought many rough seas, but it's her fight with breast cancer that's given her new strength ...

                  Flag as irrelevant  

Zumba enthusiasts raise funds for breast cancer research

New Bern Sun Journal

Zumba Party in Pink participants go through high-energy workouts Saturday during a fundraiser at the Stanly Hall on Pollock Street for breast cancer ...

                  Flag as irrelevant  

Share this story

Herald Sun

The launch of the Olivia Newton-John Cancer Research Institute comes as the State Government reveals it will give Victorian scientists $4.5 million to ...

                  Flag as irrelevant  

Avon Walk for Breast Cancer Raises Millions For Research and Treatment

KEYT

It's the 12th year of the weekend-long fundraising event to raise money for breast cancer research and provide access to screening and treatment for ...

                  Flag as irrelevant  

PerezHilton.com

'Stand Up to Cancer' raises more than $109 million

Yahoo News

The star-studded "Stand Up to Cancer" telecast raised more than $109 million in pledges for cancer research over the weekend, organizers of the ...

                  Flag as irrelevant  

The Guardian

Cancer services weakened by coalition's NHS shakeup, says report

The Guardian

The report by Cancer Research UK said that 'cracks are beginning

----- Message truncated -----

Cancer alert

Sent from my iPad

Begin forwarded message:

From: Mail Delivery Subsystem <mailer-daemon@google.com>
Date: August 14, 2014 12:48:02 PM CDT
To: bobbygmartin1938@gmail.com
Subject: Delivery Status Notification (Failure)

Delivery to the following recipient failed permanently:

    bobbygmartin1938.casperc@blogger.com

----- Original message -----

X-Received: by 10.66.147.227 with SMTP id tn3mr6809652pab.4.1408038482760;
       Thu, 14 Aug 2014 10:48:02 -0700 (PDT)
Return-Path: <bobbygmartin1938@gmail.com>
Received: from mail-oi0-x231.google.com (mail-oi0-x231.google.com [2607:f8b0:4003:c06::231])
       by gmr-mx.google.com with ESMTPS id e2si516135igg.3.2014.08.14.10.48.02
       for <bobbygmartin1938.casperc@blogger.com>
       (version=TLSv1 cipher=ECDHE-RSA-RC4-SHA bits=128/128);
       Thu, 14 Aug 2014 10:48:02 -0700 (PDT)
Received-SPF: pass (google.com: domain of bobbygmartin1938@gmail.com designates 2607:f8b0:4003:c06::231 as permitted sender) client-ip=2607:f8b0:4003:c06::231;
Authentication-Results: gmr-mx.google.com;
      spf=pass (google.com: domain of bobbygmartin1938@gmail.com designates 2607:f8b0:4003:c06::231 as permitted sender) smtp.mail=bobbygmartin1938@gmail.com;
      dkim=pass header.i=@gmail.com;
      dmarc=pass (p=NONE dis=NONE) header.from=gmail.com
Received: by mail-oi0-f49.google.com with SMTP id u20so962723oif.22
       for <bobbygmartin1938.casperc@blogger.com>; Thu, 14 Aug 2014 10:48:02 -0700 (PDT)
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed;
       d=gmail.com; s=20120113;
       h=subject:references:from:content-type:message-id:date:to
        :content-transfer-encoding:mime-version;
       bh=hQ9fevEksEDazN7TY0C0E6I1YYSV7qcLEv8XGcfUZ/g=;
       b=dHF4lx2J0i82eJ1IaxC+PTnsUGfBTo5OYMmlpZRuXe2sUb2HkLAZdtNxWTfcrBwbis
        x6JFvKxaJkIIOMAjityyaYrzgFixlkrhg0UQlbcInfGCupjWqX9EUS2bw432mh92xwkU
        fMF1gMfWMATMIgfL/JalTZXgG83EWzptmwi+8m/2AVAgl6+YgFg+tq8yqwtCFCDZq2ha
        gltgGdDwD6JyslWCNyhAoIQUw4OvzSghqh6SEnDgEYe81TZWU1oS01cfHABj26DnaDsJ
        3IqRHoYtmPTOkTRKUYFKBwBf9V8lDTW0iSgO8scgfG8OpF4RCmCjnUcxpSUXgAbetox4
        ZE0A==
X-Received: by 10.60.158.8 with SMTP id wq8mr14903204oeb.40.1408038482381;
       Thu, 14 Aug 2014 10:48:02 -0700 (PDT)
Return-Path: <bobbygmartin1938@gmail.com>
Received: from [192.168.1.33] (64-250-218-20.dyn.hsi.pldi.net. [64.250.218.20])
       by mx.google.com with ESMTPSA id bz3sm8116629oec.10.2014.08.14.10.48.01
       for <bobbygmartin1938.casperc@blogger.com>
       (version=TLSv1 cipher=ECDHE-RSA-RC4-SHA bits=128/128);
       Thu, 14 Aug 2014 10:48:01 -0700 (PDT)
Subject: Fwd: Google Alert - Space cancer research
References: <e89a8fb1f70ef9f3e305009a470d@google.com>
From: Bobby Martin <bobbygmartin1938@gmail.com>
Content-Type: multipart/alternative;
   boundary=Apple-Mail-1-234554490
X-Mailer: iPad Mail (8H7)
Message-Id: <A9E67E87-1967-43E9-8419-5E4556E63771@gmail.com>
Date: Thu, 14 Aug 2014 12:48:01 -0500
To: bobbygmartin1938.casperc@blogger.com
Content-Transfer-Encoding: 7bit
Mime-Version: 1.0 (iPad Mail 8H7)



Sent from my iPad

Begin forwarded message:

From: Google Alerts <googlealerts-noreply@google.com>

Date: August 14, 2014 12:31:56 PM CDT

To: bobbygmartin1938@gmail.com

Subject: Google Alert - Space cancer research

       

Space cancer research

Daily update ⋅ August 14, 2014

NEWS    

Stanley Consultants: Operating Rooms and Cancer Research Lab Air Handling Unit Replacements

Consulting-Specifying Engineer

Stanley Consultants: Operating Rooms and Cancer Research Lab Air ... The project design was complicated by space limitations on the mezzanine.

                  Flag as irrelevant  

Edit this alert

You have received this email because you have subscribed to Google Alerts.

Unsubscribe | View all your alerts

 Receive this alert as RSS feed

Send Feedback